Insulin-like growth factor receptor 1 (IGFR-1) expression is significantly associated with longer survival in non-small cell lung cancer (NSCLC) patients treated with gefitinib

被引：0
|
作者：
Cappuzzo, F.
Ceresoli, G.
Bartolini, S.
Toschi, L.
Finocchiaro, G.
Domenichini, I.
Tallini, G.
Santoro, A.
Crino, L.
Hirsch, F.
机构：
[1] Bellaria Hosp, Bologna, Italy
[2] Ist Clin Humanitas, Milan, Italy
[3] CINECA, Bologna, Italy
[4] Ist Clin Humanitas, Bologna, Italy
[5] Colorado Canc Ctr, Aurora, CO USA
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [31] Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer
    Tran, T. N.
    Selinger, C. I.
    Yu, B.
    Ng, C. C.
    Kohonen-Corish, M. R. J.
    McCaughan, B.
    Kennedy, C.
    O'Toole, S. A.
    Cooper, W. A.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (11) : 985 - 991
  • [32] Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review
    Yin, Ming
    Guan, Xiaoxiang
    Liao, Zhongxin
    Wei, Qingyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 101 - 114
  • [33] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    LUNG CANCER, 2005, 49 : S112 - S113
  • [34] Inherited EGFR variants and survival in patients with non-small cell lung cancer (NSCLC) treated with gefitinib.
    Gregorc, V
    Hidalgo, M
    Spreafico, A
    Aondio, G
    Cusatis, G
    Marsh, S
    Steinberg, SM
    Ludovini, V
    Villa, E
    Sparreboom, A
    Baker, SD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9079S - 9079S
  • [35] miR-497 may enhance the sensitivity of non-small cell lung cancer cells to gefitinib through targeting the insulin-like growth factor-1 receptor
    Ma, Wei
    Feng, Weiye
    Tan, Jie
    Xu, Airu
    Hue, Yudong
    Nine, Lanlan
    Kang, Yanhong
    Wang, Liuqian
    Zhao, Ziwen
    JOURNAL OF THORACIC DISEASE, 2018, 10 (10) : 5889 - 5897
  • [36] Insulin-like growth factor type I receptor: A new target in the treatment of non-small cell lung cancer patients
    Heller G.
    Zöchbauer-Müller S.
    memo - Magazine of European Medical Oncology, 2010, 3 (2) : 81 - 84
  • [37] Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib
    Jackman, David M.
    Yeap, Beow Y.
    Sequist, Lecia V.
    Lindeman, Neal
    Holmes, Alison J.
    Joshi, Victoria A.
    Bell, Daphne W.
    Huberman, Mark S.
    Halmos, Balazs
    Rabin, Michael S.
    Haber, Daniel A.
    Lynch, Thomas J.
    Meyerson, Matthew
    Johnson, Bruce E.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2006, 12 (13) : 3908 - 3914
  • [38] Targeting the insulin-like growth factor receptor/Insulin receptor and Src signaling network for the treatment of non-small cell lung cancer
    Min, Hye-Young
    Yun, Hye Jeong
    Lee, Hyo-Jong
    Cho, Jaebeom
    Jang, Hyun-Ji
    Kim, Kyung Min
    Kim, Woo-Young
    Oh, Seung-Hyun
    Liu, Diane
    Lee, J. Jack
    Hong, Waun K.
    Wistuba, Ignacio I.
    Lee, Ho-Young
    CANCER RESEARCH, 2014, 74 (19)
  • [39] Expressions of Insulin-Like Growth Factor Receptor-1 and Insulin-Like Growth Factor Binding Protein 3 in Advanced Non-Small-Cell Lung Cancer
    Kim, Young Hak
    Sumiyoshi, Shinji
    Hashimoto, Seiji
    Masago, Katsuhiro
    Togashi, Yosuke
    Sakamori, Yuichi
    Okuda, Chiyuki
    Mio, Tadashi
    Mishima, Michiaki
    CLINICAL LUNG CANCER, 2012, 13 (05) : 385 - 390
  • [40] Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
    Ma, Wei
    Kang, Yanhong
    Ning, Lanlan
    Tan, Jie
    Wang, Hanping
    Ying, Yi
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (04) : 2853 - 2862
12345